Memoral Sloan-Kettering Cancer Center at Phelps

Sleepy Hollow, New York 10591

0 studies enrolling now · 15 studies all time

What they study most

Advanced Lung Cancer, Breast Cancer, Colorectal Cancer, EGFR-Mutant Lung Cancer, Lung Adenocarcinoma, Lung Cancer, Malignant Pleural Mesothelioma, Multiple Myeloma, Non-Small Cell Lung Cancer, Oligometastatic Lung Adenocarcinoma, Pancreatic Adenocarcinoma, Prostate Cancer

Studies at this site

• Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance — Completed
• 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy — Completed
• Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers — Completed
• Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D — Completed
• Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma — Completed
• Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L — Completed
• Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib — Completed
• Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer — Completed
• Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life — Completed
• Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations — Completed
• Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer — Completed
• Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma — Withdrawn before enrolling
• Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients — Completed
• Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer — Completed
• Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib — Completed